@dplane
I'd tend to agree but I have to admit to feeling that MSB was basically telegraphing a delay on CLBP and CHF. That's disappointing and there's no point sugar-coating it, they should have just come out and said it.
Further, I see the recruitment figures quoted for the ARDS trial as indicating a delay also. I'm now assuming the final patients will be dosed mid to late September, with the 30 days to the endpoint added on to that. If the trial is stopped, which I'm not expecting to happen, we'll probably only have around 200 patients dosed.
At least we have the upcoming public meeting on Ryoncil coming up on the 13th of August. I'm expecting many of us here may not get much sleep that night.
Ann: COVID-19/GVHD Update, Quarterly Report and Appendix 4C, page-172
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
0.058(5.93%) |
Mkt cap ! $1.107B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.03 | 99.0¢ | $1.813M | 1.793M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 29266 | $1.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 63855 | 17 |
View Market Depth
| Last trade - 11.25am 04/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |